StonvexLoading…
StonvexStonvexStonvexCore line items from CETX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.19M | $16.13M | $76.49M | $57.96M |
Operating Income | $-4.98M | $-2.81M | $509.83K | $1.69M |
Net Income | $-19.65M | $-20.56M | $-28.11M | $-24.91M |
EPS (Diluted) | $-2.97 | $-7.91 | $-210.88 | $-11.68 |
Total Assets | $70.74M | $60.33M | $47.79M | $46.96M |
Total Liabilities | $36.03M | $31.24M | $39.07M | $43.11M |
Cash & Equivalents | $6.57M | $20.51M | $4.97M | $7.03M |
Free Cash Flow OCF − CapEx | $-5.65M | $-1.08M | $-1.77M | $1.98M |
Shares Outstanding | 10.08M | 8.60M | 830.61K | 3.51M |